While these treatments are highly effective, some patients can notice fatigue or low energy levels , particularly during the first few weeks of treatment
Most patients begin noticing some weight loss within the first few weeks of starting a GLP-1 agonist, especially as the dose is gradually increased to the optimal maintenance level
Retatrutide has not yet been approved by the FDA
"The potential for overdose is enormous," Melbourne-based gastroenterologist Darcy Holt said
In a double-blind, placebo-controlled, phase 2b trial, patients with diabetes were administered all doses of tirzepatide, dulaglutide, or placebo
Weight Management at Premise Health At Premise Health, our weight management program is primary care-led, evidence-based, and supported by an interdisciplinary care team that can include clinical pharmacy, nutrition, behavioral health, and more